(c) 2024 PillSync.com

Methylphenidate Hydrochloride 36 mg

1 INDICATIONS AND USAGE Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65 [see Clinical Studies (14) ] . Methylphenidate hydrochloride extended-release tablets are a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. ( 1 )

Trigen Laboratories, LLC


11 months ago ROUND WHITE TL 708 Methylphenidate Hydrochloride 36 mg

ROUND WHITE TL 708

11 months ago ROUND WHITE TL 708 Methylphenidate Hydrochloride 36 mg

TL 708 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, USP are available in 18, 27, 36, 54, and 72 mg strengths. The 18 mg tablets are yellow with “TL706” imprinted in black ink, 27 mg tablets are gray with “TL707” imprinted in black ink, 36 mg tablets are white with “TL708” imprinted in black ink, 54 mg tablets are pink with “TL709" imprinted in black ink, and 72 mg tablets are blue with “TL710” imprinted in black ink. The tablets are supplied: 18 mg 100-count bottle NDC 13811-706-10 27 mg 100-count bottle NDC 13811-707-10 36 mg 100-count bottle NDC 13811-708-10 54 mg 100-count bottle NDC 13811-709-10 72 mg 30-count bottle NDC 13811-710-30 72 mg 100-count bottle NDC 13811-710-10 Storage and Handling Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from humidity.


More pills like ROUND TL 708












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site